These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19330195)

  • 21. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
    Scheltens P; Korf ES
    Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of the dopaminergic system in differential diagnosis of dementia.
    Tatsch K
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S51-7. PubMed ID: 18214473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
    Jolepalem P; Balon HR; Wong CY; Wu D
    J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is brain SPECT useful in degenerative dementia diagnosis?
    Farid K; Caillat-Vigneron N; Sibon I
    J Comput Assist Tomogr; 2011; 35(1):1-3. PubMed ID: 21160432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction.
    Matsuda H; Kanetaka H; Ohnishi T; Asada T; Imabayashi E; Nakano S; Katoh A; Tanaka F
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1502-5. PubMed ID: 12397471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of emission tomography in dementia.
    Perani D
    Ital J Neurol Sci; 1999; 20(5 Suppl):S254-7. PubMed ID: 10662962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of positron emission tomography for diagnosis of dementia.
    Ishii K
    Ann Nucl Med; 2002 Dec; 16(8):515-25. PubMed ID: 12593416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of repeated ictal SPET for the localization of epileptogenic zones in intractable epilepsy.
    Lee DS; Lee SK; Kim YK; Kang E; Lee JS; Chung JK; Lee MC
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):607-14. PubMed ID: 11976798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign.
    Bonte FJ; Harris TS; Roney CA; Hynan LS
    J Nucl Med; 2004 May; 45(5):771-4. PubMed ID: 15136625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
    Waragai M; Mizumura S; Yamada T; Matsuda H
    Dement Geriatr Cogn Disord; 2008; 26(6):547-55. PubMed ID: 19066428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of SPET imaging in dementia.
    Talbot PR; Testa HJ
    Nucl Med Commun; 1995 Jun; 16(6):425-37. PubMed ID: 7675354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPECT imaging in dementia.
    Pimlott SL; Ebmeier KP
    Br J Radiol; 2007 Dec; 80 Spec No 2():S153-9. PubMed ID: 18445745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke.
    Silverman DH; Phelps ME
    Mol Genet Metab; 2001; 74(1-2):128-38. PubMed ID: 11592810
    [No Abstract]   [Full Text] [Related]  

  • 39. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.